287 related articles for article (PubMed ID: 8737030)
1. Daytime glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary sulphonylurea failure: a 1-year follow-up.
Clauson P; Karlander S; Steen L; Efendic S
Diabet Med; 1996 May; 13(5):471-7. PubMed ID: 8737030
[TBL] [Abstract][Full Text] [Related]
2. Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure.
Landstedt-Hallin L; Adamson U; Arner P; Bolinder J; Lins PE
Diabetes Care; 1995 Aug; 18(8):1183-6. PubMed ID: 7587856
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?
Trischitta V; Italia S; Raimondo M; Guardabasso V; Licciardello C; Runello F; Mazzarino S; Sangiorgi L; Anello M; Vigneri R
J Endocrinol Invest; 1998 Dec; 21(11):744-7. PubMed ID: 9972673
[TBL] [Abstract][Full Text] [Related]
4. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.
Yki-Järvinen H; Dressler A; Ziemen M;
Diabetes Care; 2000 Aug; 23(8):1130-6. PubMed ID: 10937510
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
Cusi K; Cunningham GR; Comstock JP
Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
[TBL] [Abstract][Full Text] [Related]
6. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Chow CC; Tsang LW; Sorensen JP; Cockram CS
Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
[TBL] [Abstract][Full Text] [Related]
7. Comparison of combined therapies in treatment of secondary failure to glyburide.
Trischitta V; Italia S; Mazzarino S; Buscema M; Rabuazzo AM; Sangiorgio L; Squatrito S; Vigneri R
Diabetes Care; 1992 Apr; 15(4):539-42. PubMed ID: 1499473
[TBL] [Abstract][Full Text] [Related]
8. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.
Bastyr EJ; Stuart CA; Brodows RG; Schwartz S; Graf CJ; Zagar A; Robertson KE
Diabetes Care; 2000 Sep; 23(9):1236-41. PubMed ID: 10977012
[TBL] [Abstract][Full Text] [Related]
9. Acarbose vs. bedtime NPH insulin in the treatment of secondary failures to sulphonylurea-metformin therapy in type 2 diabetes mellitus.
López-Alvarenga JC; Aguilar-Salinas CA; Velasco-Perez ML; Arita-Melzer O; Guillen LE; Wong B; Brito G; Mercado V; Gómez-Pérez FJ; Rull-Rodrigo JA
Diabetes Obes Metab; 1999 Jan; 1(1):29-35. PubMed ID: 11221809
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different insulin regimens in elderly patients with NIDDM.
Wolffenbuttel BH; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
Diabetes Care; 1996 Dec; 19(12):1326-32. PubMed ID: 8941458
[TBL] [Abstract][Full Text] [Related]
11. Combination-therapy with bedtime nph insulin and sulphonylureas gives similar glycaemic control but lower weight gain than insulin twice daily in patients with type 2 diabetes.
Olsson PO; Lindström T
Diabetes Metab; 2002 Sep; 28(4 Pt 1):272-7. PubMed ID: 12442064
[TBL] [Abstract][Full Text] [Related]
12. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
13. Comparison of bedtime NPH insulin or metformin combined with glibenclamide in secondary sulphonylurea failure in obese type II (NIDDM) patients.
Niazi R; Muzaffar Z
J Pak Med Assoc; 1998 Nov; 48(11):336-8. PubMed ID: 10323055
[TBL] [Abstract][Full Text] [Related]
14. Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes.
Sargin H; Sargin M; Altuntaş Y; Sengül AM; Orbay E; Seber S; Uçak S; Yayla A
Diabetes Res Clin Pract; 2003 Nov; 62(2):79-86. PubMed ID: 14581144
[TBL] [Abstract][Full Text] [Related]
15. Insulin in type 2 diabetes: a useful alternative despite limited assessment based on surrogate endpoints.
Prescrire Int; 2005 Oct; 14(79):187-93. PubMed ID: 16285076
[TBL] [Abstract][Full Text] [Related]
16. Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failure.
Altuntas Y; Ozen B; Ozturk B; Sengul A; Ucak S; Ersoy O; Karul S
Diabetes Obes Metab; 2003 Nov; 5(6):371-8. PubMed ID: 14617222
[TBL] [Abstract][Full Text] [Related]
17. Bed time NPH-insulin plus combined sulfonylurea-biguanide oral therapy for treating refractory non insulin dependent diabetic patients.
di Cianni G; Benzi L; Ciccarone AM; Cecchetti P; Navalesi R
Diabete Metab; 1992; 18(6):468-9. PubMed ID: 1297606
[No Abstract] [Full Text] [Related]
18. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial.
Yki-Järvinen H; Ryysy L; Nikkilä K; Tulokas T; Vanamo R; Heikkilä M
Ann Intern Med; 1999 Mar; 130(5):389-96. PubMed ID: 10068412
[TBL] [Abstract][Full Text] [Related]
19. Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas.
Fanghänel G; Sánchez-Reyes L; Trujillo C; Sotres D; Espinosa-Campos J
Diabetes Care; 1996 Nov; 19(11):1185-9. PubMed ID: 8908377
[TBL] [Abstract][Full Text] [Related]
20. Indirect comparison of lixisenatide versus neutral protamine Hagedorn insulin as add-on to metformin and sulphonylurea in patients with type 2 diabetes mellitus.
Fournier M; Germe M; Theobald K; Scholz GH; Lehmacher W
Ger Med Sci; 2014; 12():Doc14. PubMed ID: 25332702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
